Bioinformatics Studies Provide Insight into Possible Target and Mechanisms of Action of Nobiletin against Cancer Stem Cells

OBJECTIVE: Nobiletin treatment on MDA-MB 231 cells reduces the expression of CXC chemokine receptor type 4 (CXCR4), which is highly expressed in cancer stem cell populations in tumor patients. However, the mechanisms of nobiletin in cancer stem cells (CSCs) remain elusive. This study was aimed to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermawan, Adam, Putri, Herwandhani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437309/
https://www.ncbi.nlm.nih.gov/pubmed/32212785
http://dx.doi.org/10.31557/APJCP.2020.21.3.611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437309/
https://www.ncbi.nlm.nih.gov/pubmed/32212785
http://dx.doi.org/10.31557/APJCP.2020.21.3.611

Ejemplares similares